Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 19 04:00PM ET
0.7609
Dollar change
-0.0022
Percentage change
-0.29
%
Index- P/E- EPS (ttm)-15.19 Insider Own9.12% Shs Outstand7.40M Perf Week-9.31%
Market Cap5.68M Forward P/E- EPS next Y- Insider Trans-5.26% Shs Float6.78M Perf Month18.91%
Income-18.29M PEG- EPS next Q- Inst Own1.48% Short Float1.97% Perf Quarter34.10%
Sales0.00M P/S- EPS this Y- Inst Trans- Short Ratio0.06 Perf Half Y-86.23%
Book/sh0.46 P/B1.66 EPS next Y- ROA-463.93% Short Interest0.13M Perf Year-97.51%
Cash/sh0.63 P/C1.21 EPS next 5Y- ROE-1046.96% 52W Range0.37 - 38.93 Perf YTD0.52%
Dividend Est.- P/FCF- EPS past 5Y- ROI-540.31% 52W High-98.05% Beta-0.26
Dividend TTM- Quick Ratio3.16 Sales past 5Y0.00% Gross Margin- 52W Low104.54% ATR (14)0.14
Dividend Ex-Date- Current Ratio3.16 EPS Y/Y TTM28.34% Oper. Margin0.00% RSI (14)58.96 Volatility30.55% 17.97%
Employees7 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price3.00
Option/ShortNo / No LT Debt/Eq0.00 EPS Q/Q89.15% Payout- Rel Volume0.22 Prev Close0.76
Sales Surprise- EPS Surprise- Sales Q/Q- Earnings- Avg Volume2.38M Price0.76
SMA2032.85% SMA5029.47% SMA200-80.66% Trades Volume523,963 Change-0.29%
Apr-16-24 04:30PM
Apr-12-24 07:51AM
Apr-11-24 04:30PM
Mar-13-24 08:20AM
Jan-18-24 08:30AM
08:30AM Loading…
Jan-17-24 08:30AM
Dec-22-23 02:00PM
Dec-19-23 09:30AM
Dec-12-23 09:00AM
Dec-08-23 08:30AM
Dec-07-23 09:00AM
Dec-06-23 08:00AM
Dec-01-23 01:30PM
Nov-22-23 04:10PM
10:27AM
08:30AM Loading…
08:30AM
Nov-21-23 09:00AM
Nov-20-23 03:15PM
09:15AM
Nov-17-23 03:00PM
08:00AM
Nov-15-23 06:50PM
08:30AM
Nov-10-23 09:00AM
Nov-09-23 08:30AM
08:00AM
Nov-07-23 11:15AM
08:00AM
Nov-02-23 08:30AM
Oct-31-23 08:00AM
11:30AM Loading…
Oct-30-23 11:30AM
Oct-26-23 02:42PM
01:51PM
08:00AM
Oct-18-23 10:10AM
Oct-10-23 08:00AM
Aug-30-23 08:00AM
Aug-16-23 08:30AM
Aug-09-23 04:15PM
Aug-08-23 09:00AM
Jul-24-23 08:00AM
Jul-06-23 08:00AM
Jun-22-23 08:30AM
Jun-20-23 08:30AM
Jun-14-23 08:00AM
Jun-08-23 08:00AM
Jun-01-23 08:00AM
May-15-23 04:13PM
Apr-19-23 08:30AM
Mar-29-23 07:21PM
Mar-20-23 08:00AM
Feb-27-23 10:22AM
Feb-15-23 07:30AM
Feb-03-23 08:00AM
Jan-20-23 01:31PM
Dec-14-22 08:00AM
Nov-22-22 08:00AM
Nov-17-22 08:29PM
Nov-15-22 08:00AM
Nov-08-22 08:00AM
Oct-24-22 08:00AM
Oct-03-22 08:00AM
Aug-26-22 09:50AM
08:00AM
Aug-24-22 03:27PM
PaxMedica, Inc. is a clinical stage biopharmaceutical company. It engages in the business of developing drug candidates for the treatment of autism spectrum disorder, Fragile X syndrome tremor-ataxia, and Human African Trypanosomiasis. The company was founded by Michael L. Derby on April 5, 2018 and is headquartered in Tarrytown, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rome ZacharyDirectorJan 29 '24Sale0.4881138915,148Jan 31 07:55 PM
Weisman Howard J.Chief Executive OfficerJan 29 '24Sale0.4737217537,675Jan 31 05:16 PM
LaRochelle KarenDirectorJan 29 '24Sale0.4878372,829Jan 31 05:19 PM
Coelho John FDirectorJan 29 '24Sale0.4827134,615Jan 31 05:18 PM
Rome ZacharyDirectorNov 27 '23Sale1.0335937015,959Nov 29 04:07 PM
Derby Michael10% OwnerNov 27 '23Sale1.0318519025,650Nov 29 04:08 PM
Weisman Howard J.Chairman and CEONov 27 '23Sale1.0316216638,047Nov 29 04:08 PM
LaRochelle KarenDirectorNov 27 '23Sale1.0335362,907Nov 29 04:07 PM
Coelho John FDirectorNov 27 '23Sale1.0212124,642Nov 29 04:09 PM
Rome ZacharyDirectorOct 27 '23Sale0.1816,3013,012277,390Oct 30 04:13 PM
Derby Michael10% OwnerOct 27 '23Sale0.199,1751,740439,171Oct 30 04:12 PM
Weisman Howard J.Chairman and CEOOct 27 '23Sale0.198,0491,524649,549Oct 30 04:11 PM
LaRochelle KarenDirectorOct 27 '23Sale0.191,67931749,994Oct 30 04:12 PM
Coelho John FDirectorOct 27 '23Sale0.1957010879,090Oct 30 04:12 PM
Weisman Howard J.Chairman and CEOAug 30 '23Sale0.4522,53510,053657,598Aug 30 04:09 PM
Rome ZacharyDirectorAug 30 '23Sale0.474,8012,235293,691Aug 30 04:09 PM
Weisman Howard J.Chairman and CEOAug 29 '23Sale0.489,5964,650680,133Aug 30 04:09 PM
Rome ZacharyDirectorAug 29 '23Sale0.488,7924,257298,492Aug 30 04:09 PM
Derby Michael10% OwnerAug 29 '23Sale0.486,5403,169448,346Aug 30 04:08 PM
LaRochelle KarenDirectorAug 29 '23Sale0.4845622151,673Aug 30 04:09 PM
Coelho John FDirectorAug 29 '23Sale0.49231179,660Aug 30 04:10 PM
Rome ZacharyDirectorAug 28 '23Sale0.4912,0005,862307,284Aug 30 04:09 PM
Weisman Howard J.Chairman and CEOAug 28 '23Sale0.4912,0005,858689,729Aug 30 04:09 PM
Derby Michael10% OwnerAug 28 '23Sale0.497,0003,452454,886Aug 30 04:08 PM
LaRochelle KarenDirectorAug 28 '23Sale0.502,0001,00252,129Aug 30 04:09 PM
Coelho John FDirectorAug 28 '23Sale0.5277440379,683Aug 30 04:10 PM
Rome ZacharyDirectorAug 22 '23Sale0.5430,00016,236319,284Aug 23 04:12 PM
Rome ZacharyDirectorAug 21 '23Sale0.5820,00011,626349,284Aug 23 04:12 PM